ProfileGDS4718 / 1558651_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 16% 7% 15% 5% 12% 17% 13% 7% 13% 15% 11% 12% 6% 13% 9% 16% 7% 11% 22% 9% 10% 6% 11% 16% 5% 10% 9% 13% 12% 11% 4% 10% 8% 11% 6% 9% 5% 8% 11% 8% 14% 12% 9% 22% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0211616
GSM549102patient 115, normal, homogenized [OPG study]3.687137
GSM549104patient 119, normal, homogenized [OPG study]3.9378115
GSM549108patient 138, normal, homogenized [OPG study]3.611675
GSM549119patient 077, normal, homogenized [OPG study]3.8472312
GSM549133patient 032, cancer, homogenized [OPG study]3.9777117
GSM549139patient 042, cancer, homogenized [OPG study]3.8657413
GSM549099patient 107, normal, homogenized [OPG study]3.678347
GSM549109patient 139, normal, homogenized [OPG study]3.9199713
GSM549110patient 046, normal, homogenized [OPG study]3.9798615
GSM549114patient 063, normal, homogenized [OPG study]3.7903311
GSM549122patient 082, normal, homogenized [OPG study]3.8518612
GSM549134patient 033, cancer, homogenized [OPG study]3.63496
GSM549136patient 036, cancer, homogenized [OPG study]3.8394313
GSM549140patient 044, cancer, homogenized [OPG study]3.71189
GSM549111patient 047, normal, homogenized [OPG study]3.9745416
GSM549113patient 057, normal, homogenized [OPG study]3.620477
GSM549132patient 031, cancer, homogenized [OPG study]3.7975711
GSM549137patient 038, cancer, homogenized [OPG study]4.2102422
GSM549142patient 047, cancer, homogenized [OPG study]3.816659
GSM549100patient 110, normal, homogenized [OPG study]3.772810
GSM549107patient 135, normal, homogenized [OPG study]3.615286
GSM549115patient 068, normal, homogenized [OPG study]3.7965611
GSM549116patient 072, normal, homogenized [OPG study]3.9789716
GSM549120patient 078, normal, homogenized [OPG study]3.58545
GSM549131patient 030, cancer, homogenized [OPG study]3.7401110
GSM549118patient 074, normal, homogenized [OPG study]3.767689
GSM549129patient 027, cancer, homogenized [OPG study]3.8982313
GSM549123patient 088, normal, homogenized [OPG study]3.8584212
GSM549124patient 006, cancer, homogenized [OPG study]3.8509611
GSM549126patient 015, cancer, homogenized [OPG study]3.534364
GSM549128patient 025, cancer, homogenized [OPG study]3.7523210
GSM549103patient 117, normal, homogenized [OPG study]3.73868
GSM549117patient 073, normal, homogenized [OPG study]3.825111
GSM549138patient 041, cancer, homogenized [OPG study]3.61416
GSM549141patient 045, cancer, homogenized [OPG study]3.680569
GSM549130patient 028, cancer, homogenized [OPG study]3.606075
GSM549101patient 111, normal, homogenized [OPG study]3.710388
GSM549105patient 128, normal, homogenized [OPG study]3.8099111
GSM549106patient 134, normal, homogenized [OPG study]3.671018
GSM549112patient 048, normal, homogenized [OPG study]3.9370214
GSM549125patient 011, cancer, homogenized [OPG study]3.8704212
GSM549127patient 024, cancer, homogenized [OPG study]3.734389
GSM549135patient 035, cancer, homogenized [OPG study]4.1574422